Q32 Bio (QTTB) Preferred Shares Issued (2017)

Q32 Bio (QTTB) recorded quarterly Preferred Shares Issued of $74.3 million in Q4 2017, up 262.75% quarter-over-quarter from $20.5 million in Q1 2017.

Q32 Bio (QTTB) Preferred Shares Issued (2017) Analysis & Trends

Q32 Bio's Preferred Shares Issued history runs 1 years deep, the most recent figure standing at $74.3 million for Q4 2017.

In Q4 2017, Preferred Shares Issued changed N/A year-over-year to $74.3 million; the TTM figure through Dec 2017 stood at $94.8 million (changed N/A YoY), while the FY2017 annual figure was $94.8 million, changed N/A from the prior year.
Preferred Shares Issued was $74.3 million for Q4 2017 at Q32 Bio, up from $20.5 million in the prior quarter.
In the past five years, Preferred Shares Issued ranged from a high of $74.3 million in Q4 2017 to a low of $20.5 million in Q1 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares Issued (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	-
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	-
9	Abivax	90.15 Bn	90.15 Bn	-	-
10	Q32 Bio	177.18 Mn	126.43 Mn	-	-

Download Data